.svg){kind=small}
May-2026
Sales
Trend
6-Month
Product Count
SKUs
Avg Price
YoY Sales Change
YoY Price Change
Market Insights Snapshot
In May 2026, Breakwater’s mix concentrated in Flower at 52.76% share with 1,621.10% year-over-year growth but a -17.69% month-over-month pullback, while Vapor Pens held 21.28% share with 5,030.19% YoY and -16.91% MoM. Edible expanded to 10.85% share with 28,616.42% YoY growth and a comparatively shallow -0.71% MoM, as Concentrates reached 9.04% share on 5,492.88% YoY and -10.90% MoM. Pre-Roll sat at 5.23% share with 17,710.74% YoY but a -57.18% MoM contraction, and Tincture & Sublingual remained niche at 0.83% share with a -50.08% MoM slide; the brand’s average price of $46.89 aligned with a -19.33% YoY price decline. The pattern implies outsized YoY expansion anchored by Flower and Vapor Pens but short-term demand cooling across most formats, with Edible acting as the relative MoM stabilizer and pricing compression broadening access.
The mix shift and price reset suggest Breakwater is migrating from a single-format identity toward a multi-format footprint where Flower still leads but Edible and Concentrates provide diversification, evidenced by Edible’s 10.85% share alongside a -0.71% MoM versus Flower’s -17.69% and Vapor Pens’ -16.91%. With Pre-Roll’s -57.18% MoM and Tincture & Sublingual’s -50.08% MoM indicating volatility at the tails, the near-term positioning favors core inhalables paired with an edible on-ramp, while the -19.33% YoY price move and a New Jersey Flower rank of 37 point to a value-oriented stance that trades margin for reach. The thesis is that maintaining Flower scale while nurturing Edible and Concentrates can smooth MoM swings and support a broader customer funnel without overexposure to Pre-Roll and Tincture troughs.
Competitive Landscape
Breakwater sits at rank #37 in NJ Flower in May 2026, improving 35 positions year over year from #72 while sliding 8 spots since February 2026 from #29, and this movement contrasts with competitors as Find. rose from #15 to #1 with approximately 189% YoY sales growth and Ozone held #2 despite a roughly 26% YoY sales decline; against this backdrop, Breakwater’s retreat from its peak rank of #28 in December 2025 to #37 alongside Grassroots climbing from #8 to #3 with about 40% YoY growth implies the brand’s YoY recovery has not translated into sustained share capture, signaling a need to convert momentum into consistent rank gains.
Notable Products
(Headband x ChemD) x Skunkdog Bx1 (3.5g) posted the steepest movement in May 2026 with a -43.6% month-over-month decline while holding rank 3, as DEADHEAD OG X TOM HILL HAZE (3.5g) also fell -39.2% at rank 10. Ghost Train Haze #55 Pre-Roll 2-Pack (1g) slipped -7.6% at rank 6, and three Flower SKUs still sit in the top 10 despite two double-digit drops, implying core inhalables are yielding share to other formats. With Edibles occupying rank 1 and rank 4 and a CBD-forward edible at rank 9 dropping -22.9%, the mix points to THC-led gummies consolidating demand even as value in high-CBD formats softens. The pattern implies Breakwater is tilting from traditional Flower toward higher-velocity Edibles, suggesting near-term emphasis on gummy innovation over strain breadth.
Top Selling Cannabis Brands
Data for this report comes from real-time sales reporting by participating cannabis retailers via their point-of-sale systems, which are linked up with Headset’s business intelligence software. Headset’s data is very reliable, as it comes digitally direct from our partner retailers. However, the potential does exist for misreporting in the instance of duplicates, incorrectly classified products, inaccurate entry of products into point-of-sale systems, or even simple human error at the point of purchase. Thus, there is a slight margin of error to consider. Brands listed on this page are ranked in the top twenty within the market and product category by total retail sales volume.
